Report Interpretation

Overview

This is a Q4 FY26 preview for Siemens. J.P. Morgan expects the company’s positive year-to-date operating momentum to continue, led by Smart Infrastructure, a recovering Digital Industries division and strong Mobility orders, and reiterates Overweight with an unchanged €345 target price.

Core views

J.P. Morgan expects Siemens to report Q4 FY26 results on 12 November with underlying trends remaining constructive into Q4 and FY27. Its forecast for industrial orders excluding Healthineers is €19.8bn, 11% above Bloomberg consensus of €17.8bn, largely because its Mobility order forecast is about 35% above consensus. It forecasts industrial revenue excluding Healthineers of €16.2bn versus €15.9bn consensus and industrial profit excluding Healthineers of €2.8bn, about 5% ahead of consensus. Across Digital Industries, Smart Infrastructure and Mobility, the report’s profit assumptions are respectively about 4%, 6% and 3% above consensus. For Digital Industries, the report models Q4 orders of about €5.7bn and sales of €5.5bn, implying roughly 8% organic growth and a book-to-bill ratio above 1x. It expects software ARR growth above 10%, within the normal range, as further evidence against concerns over the software business. The forecast 19.2% divisional margin includes approximately €45m of severance. J.P. Morgan believes a recovery in discrete automation should become more evident and that management’s Q3 margin guidance, which reflected business mix, was pragmatic or potentially conservative. Smart Infrastructure is expected to remain a principal source of strength. J.P. Morgan forecasts €7.5bn of orders, supported by strong data-center demand and related infrastructure spending, with revenue of €7.0bn, roughly 11% organic growth, and a 20.2% margin including €22m of severance. For Mobility, it forecasts orders of €6.5bn, within a €6bn-€7bn range, but stresses that the timing of large contracts can make orders unusually volatile. It models €3.6bn of Mobility sales, around 11% organic growth, and an 8.9% margin. The quarterly refinements have only an immaterial effect on longer-term estimates: changes from orders through EPS are generally within plus or minus 1% for FY26 and beyond. J.P. Morgan forecasts FY26 revenue of €83.0bn, adjusted EPS of €11.73 and 5.2% revenue growth; for FY27 it forecasts revenue of €89.9bn, adjusted EPS of €14.12 and 8.3% revenue growth. Its FY27 EPS estimate is 10% above Bloomberg consensus, while FY26 EPS is 5% above. The report expects margin and cash generation to improve as the group shifts from structural change and elevated investment toward execution, growth, returns and cash generation. The longer-term thesis also rests on portfolio simplification. J.P. Morgan argues that Siemens’ eight-year simplification program has created a business with stronger growth prospects, higher gross and operating margins, and more predictable free cash flow. The company’s 67% Siemens Healthineers stake, valued by the report at approximately €32bn, is described as the next major step; Siemens plans to return around 30% of Healthineers to Siemens shareholders in 2027, subject to approval at the February AGM. The report views Siemens’ exposure to automation, software, electrification and mobility as capable of delivering above-sector organic growth over multiple years. The €345 December 2027 target is unchanged and is based on a sum-of-the-parts valuation, supplemented by reverse-DCF work. The SOTP applies the market value of Siemens Energy and the MedTech team’s fair-value view for Healthineers, then applies a 10% holding-company discount. J.P. Morgan says it uses conservative multiples, generally below peer-group averages. Its SOTP base case produces an implied share price of €354.1, equivalent to a 25% premium to the €284.2 reference share price in the valuation table.

Analysis framework

J.P. Morgan combines company discussions, top-down indicators and peer read-throughs to refine quarterly divisional forecasts, then compares those forecasts with Bloomberg consensus. It assesses Siemens through order intake, revenue growth, margins and earnings across Digital Industries, Smart Infrastructure and Mobility, while using reverse-DCF and sum-of-the-parts valuation to set the target price.

Methodology notes

• Industry AnalysisSupply-demand framework

  Divisional order, revenue and margin analysis

  The report links demand in data centers, infrastructure, automation and mobility to expected orders, sales growth and profitability by Siemens division.

• Valuation methodsSOTP (Sum-of-the-Parts) Valuation

  Sum-of-the-parts valuation

  J.P. Morgan values Siemens’ businesses separately, incorporates stakes including Siemens Energy and Healthineers, and applies a 10% holding-company discount.

• Valuation methodsDCF (Discounted Cash Flow)

  Reverse-DCF analysis

  The report states that reverse-DCF analysis is used alongside SOTP as part of its unchanged price-target methodology.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Siemens (SIEGn.F, SIE GR)

  Primary covered company; expected to benefit from resilient infrastructure demand, Digital Industries recovery and Mobility order strength.

  Strengths

  Exposure to automation, software, electrification and mobility; improving margins, returns and cash generation; portfolio simplification.

  Weaknesses

  Digital Industries margins have faced pressure following demand normalization and customer/distributor destocking.

  Comparison

  J.P. Morgan’s FY27 EPS forecast of €14.12 is 10% above Bloomberg consensus of €12.84.

  Risks

  A prolonged Healthineers exit, value-destructive M&A, delayed Digital Industries recovery, or a lower valuation multiple tied to German macro perceptions.

• Siemens Healthineers

  Controlled stake and portfolio-simplification component; Siemens plans to return around 30% to shareholders in 2027.

  Strengths

  The report cites a positive update on a new radiotherapy platform and values the 67% stake at approximately €32bn.

  Weaknesses

  Its pre-close messaging has not yet been incorporated into the Siemens forecasts.

  Comparison

  The SOTP uses J.P. Morgan’s MedTech team fair-value view for Healthineers.

  Risks

  A protracted separation or distribution process would be negative for Siemens shares.

Key data

• Q4 FY26 industrial orders ex-Healthineers€19.8bn11% above Bloomberg consensus of €17.8bn.
• Q4 FY26 Digital Industries margin19.2%Includes approximately €45m of severance.
• Q4 FY26 Smart Infrastructure orders€7.5bnDriven by data-center and associated infrastructure demand.
• Q4 FY26 Mobility orders€6.5bnLarge orders can make the result volatile.
• FY27 adjusted EPS forecast€14.1210% above Bloomberg consensus of €12.84.
• SOTP base-case share price€354.1Implied 25% premium to the €284.2 reference share price.

Impact & implications

The report argues that continued strength in Smart Infrastructure, a more visible Digital Industries recovery and robust Mobility orders support a positive underlying outlook through FY27. Portfolio simplification and the planned Healthineers distribution are viewed as additional longer-term value drivers.

Risks

• A protracted Siemens Healthineers exit or distribution would be negative for Siemens shares.
• Further acquisitions at high multiples, or disposals and partnerships, could reduce value in the short term.
• A slower-than-expected Digital Industries recovery would remain important given the division’s flagship role.
• A material deterioration in perceptions of the German economy or stimulus plans could lower Siemens’ valuation multiple because of its correlation with the DAX.

What to watch

• Siemens’ Q4 FY26 results on 12 November, particularly industrial orders, divisional margins and Mobility contract timing.
• Evidence of a discrete-automation recovery and Digital Industries software ARR growth above 10%.
• Data-center demand and order momentum in Smart Infrastructure.
• The December spin-out report and February AGM approval process for the Siemens Healthineers transaction.